![Eylea outperforms Avastin for diabetic macular edema with moderate or worse vision loss | National Institutes of Health (NIH) Eylea outperforms Avastin for diabetic macular edema with moderate or worse vision loss | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2016/20160229-eye-exam.jpg?itok=kU2HiNRJ×tamp=1456519027)
Eylea outperforms Avastin for diabetic macular edema with moderate or worse vision loss | National Institutes of Health (NIH)
![Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis | International Journal of Retina and Vitreous | Full Text Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis | International Journal of Retina and Vitreous | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40942-019-0167-x/MediaObjects/40942_2019_167_Fig1_HTML.png)
Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis | International Journal of Retina and Vitreous | Full Text
![Cells | Free Full-Text | Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema Cells | Free Full-Text | Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema](https://www.mdpi.com/cells/cells-11-01950/article_deploy/html/images/cells-11-01950-g001.png)
Cells | Free Full-Text | Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema
![Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study | Scientific Reports Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-38248-1/MediaObjects/41598_2018_38248_Fig1_HTML.png)
Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study | Scientific Reports
![Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept - Ophthalmology Retina Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept - Ophthalmology Retina](https://ophthalmologyretina.org/cms/attachment/0bbb54b0-3eaf-42ec-9fb9-dd13378a95a9/gr1_lrg.jpg)
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept - Ophthalmology Retina
![Translating evidence into practice: recommendations by a UK expert panel on the use of aflibercept in diabetic macular oedema | Eye Translating evidence into practice: recommendations by a UK expert panel on the use of aflibercept in diabetic macular oedema | Eye](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41433-019-0615-8/MediaObjects/41433_2019_615_Fig1_HTML.png)
Translating evidence into practice: recommendations by a UK expert panel on the use of aflibercept in diabetic macular oedema | Eye
![Evidence-Based Guidelines for Management of Diabetic Macular Edema - Sophie J. Bakri, Jeremy D. Wolfe, Carl D. Regillo, Harry W. Flynn, Charles C. Wykoff, 2019 Evidence-Based Guidelines for Management of Diabetic Macular Edema - Sophie J. Bakri, Jeremy D. Wolfe, Carl D. Regillo, Harry W. Flynn, Charles C. Wykoff, 2019](https://journals.sagepub.com/cms/10.1177/2474126419834711/asset/images/large/10.1177_2474126419834711-fig1.jpeg)
Evidence-Based Guidelines for Management of Diabetic Macular Edema - Sophie J. Bakri, Jeremy D. Wolfe, Carl D. Regillo, Harry W. Flynn, Charles C. Wykoff, 2019
![Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis | International Journal of Retina and Vitreous | Full Text Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis | International Journal of Retina and Vitreous | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40942-019-0167-x/MediaObjects/40942_2019_167_Fig3_HTML.jpg)
Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis | International Journal of Retina and Vitreous | Full Text
![Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss | National Institutes of Health (NIH) Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/news-events/news-releases/2015/20150219-pupil.jpg)
Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss | National Institutes of Health (NIH)
![Reduction of Diabetic Macular Edema in the Untreated Fellow Eye Following Intravitreal Injection of Aflibercept | Ophthalmic Surgery, Lasers and Imaging Retina Reduction of Diabetic Macular Edema in the Untreated Fellow Eye Following Intravitreal Injection of Aflibercept | Ophthalmic Surgery, Lasers and Imaging Retina](https://journals.healio.com/cms/asset/e90b0841-c3d0-4fc5-9ae3-322262c8dc75/10.3928_23258160-20160419-12-fig1.jpg)